Adma Biologics (ADMA) FCF Margin (2011 - 2025)
Adma Biologics (ADMA) reported FCF Margin of 24.83% for Q4 2025, down 1554.0% on a YoY basis from 1.71% in Q4 2024, and up 3200.34% quarter-over-quarter from 0.8% in Q3 2025.
Adma Biologics (ADMA) FCF Margin (2011 - 2025) Analysis & Trends
Adma Biologics has reported FCF Margin for 13 years, with the latest figure at 24.83% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 1554.0% year-over-year to 24.83%; the trailing twelve-month figure through Dec 2025 stood at 5.45% (down 2045.0% YoY), and the FY2025 full-year result was 5.45%, down 2045.0% from the prior year.
- FCF Margin for Q4 2025 stood at 24.83%, up from 0.8% in the prior quarter.
- The five-year high for FCF Margin was 40.66% in Q2 2024, with the low at 223.07% in Q1 2021.
- Historically, FCF Margin has averaged 32.71% across 5 years, with a median of 16.38% in 2023.
- Annual changes were most pronounced in 2021 — FCF Margin surged 18912 bps — and 2025, when it tumbled 2531 bps.
- Adma Biologics' FCF Margin stood at 67.53% in 2021, then jumped by 67 bps to 22.26% in 2022, then soared by 200 bps to 22.19% in 2023, then soared by 82 bps to 40.37% in 2024, then plunged by 38 bps to 24.83% in 2025.
- The last three FCF Margin figures came in at 24.83% (Q4 2025), 0.8% (Q3 2025), and 15.34% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 24.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.83% |
| Sep 30, 2025 | -0.80% |
| Jun 30, 2025 | 15.34% |
| Mar 31, 2025 | -21.23% |
| Dec 31, 2024 | 40.37% |
| Sep 30, 2024 | 20.00% |
| Jun 30, 2024 | 40.66% |
| Mar 31, 2024 | -5.58% |
| Dec 31, 2023 | 22.19% |
| Sep 30, 2023 | 10.21% |
| Jun 30, 2023 | -11.53% |
| Mar 31, 2023 | -29.29% |
| Dec 31, 2022 | -22.26% |
| Sep 30, 2022 | -40.56% |
| Jun 30, 2022 | -22.36% |
| Mar 31, 2022 | -99.15% |
| Dec 31, 2021 | -67.53% |
| Sep 30, 2021 | -78.34% |
| Jun 30, 2021 | -206.04% |
| Mar 31, 2021 | -223.07% |